Watson 369 5 mg Pill - white capsule/oblong, 18mm
Pill with imprint Watson 369 5 mg is White, Capsule/Oblong and has been identified as Loxapine Succinate 5 mg. It is supplied by Watson Laboratories, Inc.
Loxapine is used in the treatment of Agitation; Agitated State; Schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Watson 369 5 mg
Loxapine Succinate
- Imprint
- Watson 369 5 mg
- Strength
- 5 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antipsychotic agents
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-0369
- Inactive Ingredients
-
lactose anhydrous,
benzyl alcohol,
butylparaben,
edetate calcium disodium,
gelatin,
magnesium stearate,
methylparaben,
polacrilin potassium,
propylparaben,
sodium lauryl sulfate,
sodium propionate,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
More about loxapine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (22)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antipsychotic agents
- Breastfeeding
- En español
Patient resources
- Loxapine drug information
- Loxapine (Inhalation) (Advanced Reading)
- Loxapine (Oral) (Advanced Reading)
- Loxapine Capsules
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.